Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
Open Access
- 30 January 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (7) , 1747-1757
Abstract
Background Despite optimal surgical treatment and modern adjuvant therapies, 50% of patients diagnosed with colorectal cancer die within 5 years. Immunotherapy offers an appealing complement to...Keywords
This publication has 37 references indexed in Scilit:
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Effector Memory T Cells, Early Metastasis, and Survival in Colorectal CancerNew England Journal of Medicine, 2005
- Identification of sentinel nodes in patients with colon cancerEuropean Journal of Surgical Oncology, 2005
- T-bet Regulates Metastasis Rate in a Murine Model of Primary Prostate CancerCancer Research, 2004
- Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell ProliferationThe Journal of Immunology, 2002
- Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T CellsJournal of Experimental Medicine, 2001
- Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promiseVaccine, 2001
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995